Shingles is awful, but there may be another reason to get vaccinated. It may fight dementia
A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...
FTSE 100 Live 02 April: Tariff fears hit blue-chip stocks, Raspberry Pi shares surge
FTSE 100 Live Wednesday Raspberry Pi outlook lifts sharesTopps TIles sales acceleratePier owner plans AIM exit ...
eLife20h
Estimation of Rotavirus Vaccine Effectiveness Based on Whole Genome Sequences
US. They provide convincing evidence to support their conclusion that using the whole genome, rather than previous use of two surface proteins, enhances our understanding of strain-specific vaccine ...
Shingles vaccine may also cut risk of dementia, study shows
A vaccine to fight dementia? It turns out there may already be one – shots that prevent painful shingles also appear to ...
BC Technology5h
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Zymeworks Inc., a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, ...
GSK slides Wednesday, underperforms market
GSK PLC closed 21.39% short of its 52-week high of £18.24, which the company reached on May 16th.
Zacks.com on MSN4h
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?
Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
23andMe is potentially selling more than just genetic data. The personal survey info is also a privacy problem.
Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.